Search

Optimising therapy in newly diagnosed metastatic Ewing sarcoma

Optimising tyrosine kinase inhibitor therapy in newly diagnosed metastatic Ewing sarcoma

New markers to select children with cancer for trials with PARP inhibitors

Novel biomarkers for PARP inhibitor trials for children with cancer

Do errors in the production of antibody genes cause mutations that lead to leukaemias with poor survival rates?

The Role of Cut-and-Run, an Aberrant V(D)J Recombination Reaction, in the Development of Acute Lymphoblastic Leukaemias with Poor Prognosis

High-specificity killing of brain tumour cells using the Zika virus

Towards a new therapy against childhood brain cancer: How does the Zika virus kill aggressive brain tumour cells?

Re-purposing diabetes medication to treat Ewing's sarcoma

Investigating repurposed drugs to decrease the progression of Ewing’s sarcoma

Evaluating the use of novel treatments in combination with current maintenance therapies for the on-going treatment of high-risk neuroblastomas

Evaluating the efficacy of Enhancer of Zeste Homolog 2 (EZH2) inhibitors in combination with anti-GD2/isotretinoin for the treatment of high-risk neuroblastoma: a pre-clinical study

How does neuroblastoma begin and can we use this knowledge to develop new treatments?

Dissecting the role of MYCN in neuroblastoma initiation

Fundraising ideas

Get some inspiration for fundraising, plus our A-Z of fundraising ideas!

Repurposing antihistamines to reduce treatment-related toxicity for children with WNT-medulloblastoma

Exploring a novel drug treatment for osteosarcoma

Drug repurposing targeting immunomodulatory Haem oxygenase-1 (HO-1) for prevention of osteosarcoma growth and metastasis